Skip to main content
. 2021 Jan 25;8:600427. doi: 10.3389/fpubh.2020.600427

Table 5.

Data extraction.

Author name and year Study design Intervention Location Participant Duration Measured inflammatory activity Co-morbidity type Outcome Statistical significance
Alkhalaf et al. (23) RCTs Benfotiamine (e) or placebo (c) Netherlands, 1 outpatient clinic 86 males: 39 (e) 43 (c); age: 40–75 years Health status: T2DM, UAE 12 weeks Hs-CRP, serum amyloid A (sAA), myeloperoxidase (MPO) Diabetic nephropathy Intervention insignificant on chronic low-grade inflammation All p > 0.05
Choi et al. (24) RCTs Exercise (e) and control (c) groups Korea, 1 School of Medicine 80 Females: 38 (e) 37 (c), age: 54.4 ± 6.6 years Health status: T2DM, <2 kg, sedentary lifestyle 12 weeks sRAGE, Hs-CRP, IL-6 Vascular complications, cardiometabolic risk Decreased hs-CRP, IL-6, waist circumference, systolic and diastolic blood pressure, HbA1c, glucose, AST, apolipoprotein B, and free fatty acid sRAGE to Hs-CRP (p = 0.019; r = −0.27)
Homayouni et al. (25) RCTs Hesperidin supplement or placebo Iran, 1 University Medical Clinic Total: 64; Male: Female: Age: 30–65 years Health status: T2DM, BMI <30 6 weeks TNF-α, IL-6, hs-CRP, total anti-oxidant capacity (TAC) Vascular complications Reduced levels of inflammatory markers IL-6 (p = 0.001) and hs-CRP increased (p < 0.000), TAC (p < 0.000) decreased
Schell et al. (26) Randomized crossover study Dietary raspberries USA, 1 Clinical Assessment Unit Total: 25 Male: 5 Female: 20 Age: 54 ± 4.2 years Health status: T2DM, waist circumference (men: >102, women: >89 cm) 2 days postprandial phase 1 week apart A 1-week washout phase. 10-week “diet supplement phase” of 4 weeks with 2 weeks apart (IL)-6 and hs-TNF-α Vascular complications Red raspberries significantly improved postprandial hyperglycemia and selected markers of inflammation All p > 0.05
Barzilay et al. (27) RCTs Salsalate USA Total: 227 ≥75 years Male: 130 Female: 97 Health status: T2DM, HBA1c: 7–9.5 48 weeks CRP, TNF-α, WBC types Vascular complications Lowered HbA1c, reduction in WBC, neutrophil, and lymphocyte counts indicated anti-inflammatory role. Changes in furosine was positive with CRP and TNF changes but not other glycation products p > 0.05 for CRP and TNF for furosine changes in salsalate users
Kadoglou et al. (28) RCTs Aerobic training program (exercise) Greece Total: 60 Male: 26 Female: 34 Age: 61.64 ± 4.9 years Health status: T2DM, obese, HBA1c: 6.5–8.5, no diabetic angiopathy, postmenopausal women 6 months (four times/week, 45–60 min/session) hs-CRP, IL-10, IL-18, TNF-α Cardiovascular risk, without vascular complications Exercise training improved metabolic profile and exerts anti-inflammatory effects in T2DM Reduced CRP (p = 0.04) and IL-18 (p = 0.02). Increased IL-10 (p = 0.039); suppressed IL-18/IL-10 ratio (p = 0.014)
Krysiak et al. (29) RCTs Simvastatin, fenofibrate, simvastatin + fenofibrate, and placebo Poland, 1 large Teaching Hospital Total: 190 Age: 25–75 years Male: 108 Female: 82 Health status: untreated T2DM 180 days−90 days lifestyle modification and 90 days for the intervention TNF, IL-1, IL-2, IL-6, MCP-1, plasma C reactive protein levels Systemic inflammation, atherogenic dyslipidemia Simvastatin and fenofibrate decreased monocyte release of TNF, IL-1, IL-2, IL-6, MCP-1, and lymphocyte release of IL-2, plasma C reactive protein levels. Anti-inflammatory effects of fenofibrate partly correlated with the improvement in insulin sensitivity All significant (p = 0.001), but weakly correlated for fenofibrate alone on hs-CRP (r = 0.20 to 0.29, p = 0.001)
Zarezadeh et al. (30) RCTs Ginger powder and wheat flour Iran, 1 large Teaching Hospital Total: 48 Age: 30–60 years (both genders) Male: Female: Health status: T2DM b/w 1 and 10 years 10 weeks Intercellular adhesion molecule 1 (ICAM-1) Vascular complications, cardiovascular disease Ginger supplementation decreased sICAM-1 and ADMA after intervention but was marginally significant Ginger supplement decreased sICAM-1 marginally (p = 0.097)
Mizoguchi et al. (31) RCTs 31 pioglitazone-treated and 21 glimepiride-treated patients. Serial 18F-fluorodeoxyglucose positron emission tomography (FDG-PET) imaging Japan, 1 large Teaching Hospital Total: 56 Age: 60–76 years Male: 39 Female: 13 Health Status: T2DM 4 months hs-CRP Impaired glucose tolerance, atherosclerotic plaque inflammation High-sensitivity C reactive protein was decreased by pioglitazone, whereas it was increased by glimepiride h-CRP levels decreased by pioglitazone (P < 0.01) but increased marginally by glimepiride(p < 0.05)